Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.58% | 149.06 | 0.7% | $734.24m | |
| BMY | Bristol-Myers Squibb Co. | -0.08% | 66.73 | 1.0% | $726.64m | |
| PFE | Pfizer Inc. | -0.25% | 40.51 | 0.9% | $611.72m | |
| MRK | Merck & Co., Inc. | -0.22% | 90.98 | 0.7% | $577.92m | |
| ABBV | AbbVie, Inc. | -1.40% | 88.01 | 2.3% | $545.73m | |
| LLY | Eli Lilly & Co. | -1.29% | 139.61 | 1.1% | $400.65m | |
| APLS | Apellis Pharmaceuticals, Inc. | 0.30% | 40.50 | 0.0% | $107.43m | |
| NVS | Novartis AG | 0.88% | 95.94 | 0.2% | $101.60m | |
| AZN | AstraZeneca Plc | 1.62% | 51.33 | 1.2% | $98.49m | |
| GSK | GlaxoSmithKline Plc | 1.55% | 47.89 | 0.2% | $84.36m | |
| KRTX | Karuna Therapeutics, Inc. | 9.17% | 104.52 | 0.0% | $68.78m | |
| SNY | Sanofi | 0.10% | 51.24 | 0.2% | $68.67m | |
| NVO | Novo Nordisk A/S | -0.02% | 61.30 | 0.1% | $64.41m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.24% | 211.43 | 3.5% | $64.03m | |
| TPTX | Turning Point Therapeutics, Inc. | 2.72% | 59.95 | 0.0% | $40.48m |
Company Profile
Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none. Clementia is rapidly developing its first lead product candidate, palovarotene, to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling disorder, and other diseases.